[1] Ganuza J, Llobet G, Domínguez B. R&D in the pharmaceutical industry: a world of small innovations[J]. Management Science, 2009, 55(4): 539-551. [2] Grover J M. The evolving role of collaboration in biotechnology[J]. Nature Biotechnology, 1998, 16: 31-32. [3] Bhaskaran S R, Krishnan V. Effort, revenue, and cost sharing mechanisms for collaborative new product development[J]. Management Science, 2009, 55(6): 1152-1169. [4] 王龙,康灿华.我国医药企业研发战略联盟研究[J].科技管理研究,2005,(12):111-113. [5] 天士力创新科研体系产学研合作结硕果[N].新华网—天津频道.www.tj.xinhuanet.com, 2011-09-23. [6] Brockhoff K. R&D cooperation between firms: a perceived transaction cost perspective[J]. Management Science, 1992, 38(4): 514-54. [7] Hazlett J A, Carayannis E G. Business-university virtual teaming for strategic planning[J]. Technological Forecasting and Social Change, 1998, 57(3): 261-265. [8] Santoro M D, Gopalakrishan S. Relationship dynamics between university research centers and industrial firms: their impact on technology transfer activities[J]. Journal of Technology Transfer, 2001, 26(1): 163-171. [9] 雷永,徐飞.基于不完全信息博弈的产学研联盟形成机理研究[J].科技进步与对策,2009,26(8):28-31. [10] 于春海,樊治平,周文光.基于产品创新的企业R&D联盟形成的博弈分析[J].运筹与管理,2008, 17(4):56-60. [11] Rustum R. University-industry interaction patterns[J]. Science, New Series, 1972, 178(4064): 955-960. [12] 苏敬勤.产学研合作创新的交易成本及内外部化条件[J].科研管理,1999,20(5):68-72. [13] 张米尔,武春友.产学研合作创新的交易费用[J].科学学研究,2001,19(1):89-92. [14] 谢科范,刘海林.产学研合作共建研发(R&D)实体的博弈分析[J].科学学及科学技术管理,2006,27(10):27-30. [15] 鲁若愚,傅家骥,王念星.校企合作创新的属性演化及对分配方式的影响[J].中国软科学,2003,(10):153-160. [16] 嵇忆虹,吴伟,朱庆华.产学研合作的利益分配方式分析[J].研究与发展管理,1999,11(1):36-38. [17] 任培民, 赵树然.期权-博弈整体方法与产学研结合利益最优分配[J].科研管理,2008,29(6):171-177. [18] 黄波,孟卫东,李宇雨.基于双边激励的产学研合作最优利益分配方式[J].管理科学学报,2011,14(7):31-42. [19] 李柏洲,罗小芳.基于Shapley值法的产学研合作型企业原始创新收益分配研究[J].运筹与管理,2013,22(4):220-224. [20] 詹美求,潘杰义.校企合作创新利益分配问题的博弈分析[J].科研管理,2008,29(1):8-13,28. [21] Guan J, Zhao Q J. The impact of university-industry collaboration networks on innovation in nanobiopharmaceuticals[J]. Technological Forecasting & Social Change, 2013, 80(7): 1271-1286. [22] Wu J. Cooperation with competitors and product innovation: moderating effects of technological capability and alliance with universities[J]. Industrial Marketing Management, 2014, 43(2): 199-209. [23] Hu Q H, Schwarz L B. Controversial role of GPOs in healthcare-product supply chain[J]. Production and Operations Management, 2011, 20(1): 1-15. [24] Feng Q, Lu L X Y. The strategic perils on low cost outsourcing[J]. Management Science, 2012, 58(6): 1196-1210. |